Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Canada

Vitalité Health Network becomes the first Canadian site to join Breathe BioMedical's multi-center study to advance ...
ascopubs.org

A multi-center study on the role of ACSL4 in invasion and metastasis of hepatocellular carcinoma.

Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today announced the successful completion of patient ...
EurekAlert!

Multicenter study shows U.S. hospitals vary greatly in how they define blood culture contamination

Federally funded research suggests that standardizing what defines contamination could increase accuracy of diagnoses, optimize treatments, avoid unnecessary medications and improve patient outcomes ...
ascopubs.org

Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non–Small Cell Lung Cancer (LIQUIK)

This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
TMCnet

Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the initiation of a multi-center ...